“…Numerous biological and biomedical applications, such as cell-based assays/actuators, , implantable devices, , wearable electronics, drug/chemical biomonitoring, and synthetic biology rely primarily on electrode–cell or electrode–tissue interfaces with good biocompatibility, low impedance, high signal-to-noise ratio (SNR), long-term electrochemical stability, and minimum biofouling. These applications have broad and profound impacts including broadening fundamental understanding of biological processes through organ-on-chip devices, − treating brain injuries via neuroprosthesis, − and accelerating drug discovery with multi-modal cell-based sensors. − The electrode–cell/–tissue interfaces enable spatiotemporal recording of various cellular signals, for example, intra-/extra-cellular potentials, local field potentials (LFPs), cell–cell/cell–surface impedances, as well as bioelectrical stimulation and a wide variety of electrochemical reactions. ,,,,− For intimate monitoring of cellular parameters, there is a considerably growing interest in improving spatiotemporal resolution, increasing the total field-of-view (FoV), minimizing the device invasiveness, and boosting the number of simultaneous parallel readout channels. , Consequently, enhancing spatial resolution entails aggressively trimming the electrode sizes toward subcellular features (<5 μm) and scaling the total FoV to the tissue-level monitoring (>2–3 mm), a feat that requires extremely dense yet large-scale microelectrode arrays (MEAs) on rigid or flexible substrates with high reliability. However, such extreme miniaturization of electrodes inevitably limits the electrodes’ electrochemically active area and drastically increases the electrode–electrolyte or electrode–cell interfacial impedance. , The increased interfacial impedance directly raises thermal noise that deteriorates interface SNR and consequently constrains any electrical or electrochemical detection. , Furthermore, many in vivo (e.g., pacemakers and neuroprosthetics) and in vitro (e.g., lab-on-chip devices with cell-based assays) applications demand low electrode–cell interfacial impedance to support cellular bioelectrical stimulation with minimal invasiveness.…”